|

A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening

RECRUITINGSponsored by Memorial Sloan Kettering Cancer Center
Actively Recruiting
SponsorMemorial Sloan Kettering Cancer Center
Started2026-05-20
Est. completion2028-05-20
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations7 sites

Summary

The purpose of this study is to develop a dedicated MRI scan of the pancreas (MRP) to better detect pancreatic cancer in people who are at a high risk for pancreatic cancer.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Two first-degree relatives with pancreas cancer, one being a first-degree relative to the individual
* Pathogenic mutation in APC, BRCA1, MLH1, MSH2, MSH6, PMS2, EPCAM, PALB2, or TP53 and a first/second-degree relative with pancreas cancer
* Pathogenic mutation in CDKN2A/p16, STK11, PRSS1, SPINK1/PST1, CTRC, CPA1, ATM, or BRCA2
* Meets surveillance age eligibility, which is typically age 50, or 10 years earlier than the youngest relative with pancreas cancer. For individuals with certain gene mutations, this can be earlier. All participants must be aged 21+

For this pilot MRP study, we will additionally apply the following Criteria:

* Consents to follow-up contact
* US residents
* Completed MRI with MRCP with no actionable findings related to the pancreas (e.g. a pancreatic mass)
* No metallic artifacts covering the pancreas on prior MRCP
* Scheduled for endoscopic ultrasound
* No new contraindications for MRI (e.g. new MR unsafe device)
* No history of claustrophobia or use of anxiolytic on prior MRI
* No history of abdominal surgery that may affect interpretation of either EUS or MR
* No medical conditions that confers increased and/or unacceptable risk for anesthesia

We will recruit surveillance participants who had at least one prior MRCP in the last 3 years. They must also undergo a same-day EUS procedure as part of their surveillance. Nearly all active cohort participants have had at least one recent MRCP and, on average, our Registry gastroenterologist Dr. Rolston performs EUS in \~260 surveillance participants per year. Accordingly, it is highly feasible to recruit more than 79 participants in the grant period, and recruitment is constrained by budget.

* Documentation of Disease

  o No pathologic confirmation of disease is necessary
* Definition of Disease N/A
* Not Pregnant and Not Nursing
* Required Organ Function N/A

Exclusion Criteria:

\-

Conditions3

CancerPancreas CancerPancreatic Cancer

Locations7 sites

Memorial Sloan Kettering Basking Ridge (Consent Only)
Basking Ridge, New Jersey, 07920
Richard Kinh Gian Do, MD, PhD212-639-8591
Memorial Sloan Kettering Monmouth (Consent only)
Middletown, New Jersey, 07748
Richard Kinh Gian Do, MD, PhD212-639-8591
Memorial Sloan Kettering Bergen (Consent Only)
Montvale, New Jersey, 07645
Richard Kinh Gian Do, MD, PhD212-639-8591
Memorial Sloan Kettering Suffolk-Commack (Consent only)
Commack, New York, 11725
Richard Kinh Gian Do, MD, PhD212-639-8591
Memorial Sloan Kettering Westchester (Consent only)
Harrison, New York, 10604
Richard Kinh Gian Do, MD, PhD212-639-8591

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.